Hyperspectral image processing for the identification and quantification of lentiviral particles in fluid samples.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 08 2021
Historique:
received: 04 06 2021
accepted: 30 07 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 21 8 2021
Statut: epublish

Résumé

Optical spectroscopic techniques have been commonly used to detect the presence of biofilm-forming pathogens (bacteria and fungi) in the agro-food industry. Recently, near-infrared (NIR) spectroscopy revealed that it is also possible to detect the presence of viruses in animal and vegetal tissues. Here we report a platform based on visible and NIR (VNIR) hyperspectral imaging for non-contact, reagent free detection and quantification of laboratory-engineered viral particles in fluid samples (liquid droplets and dry residue) using both partial least square-discriminant analysis and artificial feed-forward neural networks. The detection was successfully achieved in preparations of phosphate buffered solution and artificial saliva, with an equivalent pixel volume of 4 nL and lowest concentration of 800 TU·[Formula: see text]L

Identifiants

pubmed: 34376765
doi: 10.1038/s41598-021-95756-3
pii: 10.1038/s41598-021-95756-3
pmc: PMC8355230
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16201

Subventions

Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00173
Organisme : Instituto de Salud Carlos III
ID : COV20-00173
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Instituto de Salud Carlos III
ID : COV20-00080
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Ministerio de Ciencia e Innovación
ID : EQC2019-006240-P
Organisme : Spanish National Research Agency
ID : RTI2018-094465-J

Informations de copyright

© 2021. The Author(s).

Références

Sensors (Basel). 2017 Jul 25;17(8):
pubmed: 28757564
J Virol Methods. 2006 Apr;133(1):82-91
pubmed: 16325928
J Pharm Biomed Anal. 2007 Jul 27;44(3):683-700
pubmed: 17482417
Sci Adv. 2018 May 23;4(5):eaat0496
pubmed: 29806030
Int J Comput Assist Radiol Surg. 2014 Jan;9(1):79-89
pubmed: 23797823
Proc Natl Acad Sci U S A. 2021 May 25;118(21):
pubmed: 33972412
ACS Nano. 2020 Apr 28;14(4):3822-3835
pubmed: 32223179
Viruses. 2020 May 06;12(5):
pubmed: 32384820
Mol Ther. 2002 May;5(5 Pt 1):528-37
pubmed: 11991743
Gene Ther. 2000 Jun;7(11):910-3
pubmed: 10849549
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8033-7
pubmed: 8396259
Sci Rep. 2019 Mar 13;9(1):4377
pubmed: 30867450
Lancet. 2021 May 1;397(10285):1603-1605
pubmed: 33865497
J Appl Physiol (1985). 2019 May 1;126(5):1360-1376
pubmed: 30844336
Sensors (Basel). 2014 Apr 22;14(4):7248-76
pubmed: 24759119
Food Chem. 2013 Jun 1;138(2-3):1829-36
pubmed: 23411315
Sensors (Basel). 2021 Jan 22;21(3):
pubmed: 33499335
Mol Ther. 2001 Aug;4(2):149-56
pubmed: 11482987
Chem Soc Rev. 2014 Dec 21;43(24):8200-14
pubmed: 25156745
Talanta. 2011 Jul 15;85(1):276-81
pubmed: 21645699
J Biomed Opt. 2014 Jan;19(1):10901
pubmed: 24441941
Appl Spectrosc. 2013 Nov;67(11):1215-33
pubmed: 24160873
Biotechniques. 2001 Sep;31(3):520, 522, 524, passim
pubmed: 11570495
Nat Mater. 2021 May;20(5):593-605
pubmed: 33589798
Biomed Opt Express. 2021 Mar 10;12(4):1974-1998
pubmed: 33996211

Auteurs

Emilio Gomez-Gonzalez (E)

Department of Applied Physics III, School of Engineering, Universidad de Sevilla, Camino de los Descubrimientos s/n, 41092, Sevilla, Spain. egomez@us.es.
Institute of Biomedicine of Seville, 41013, Sevilla, Spain. egomez@us.es.

Beatriz Fernandez-Muñoz (B)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza de Diseño y Traslación de Terapias Avanzadas, 41092, Sevilla, Spain.

Alejandro Barriga-Rivera (A)

Department of Applied Physics III, School of Engineering, Universidad de Sevilla, Camino de los Descubrimientos s/n, 41092, Sevilla, Spain.
School of Biomedical Engineering, The University of Sydney, Sydney, NSW, 2006, Australia.

Jose Manuel Navas-Garcia (JM)

EOD-CBRN Group, Spanish National Police, 41011, Sevilla, Spain.

Isabel Fernandez-Lizaranzu (I)

Department of Applied Physics III, School of Engineering, Universidad de Sevilla, Camino de los Descubrimientos s/n, 41092, Sevilla, Spain.
Institute of Biomedicine of Seville, 41013, Sevilla, Spain.

Francisco Javier Munoz-Gonzalez (FJ)

Department of Applied Physics III, School of Engineering, Universidad de Sevilla, Camino de los Descubrimientos s/n, 41092, Sevilla, Spain.

Ruben Parrilla-Giraldez (R)

Technology and Innovation Centre, Universidad de Sevilla, 41012, Sevilla, Spain.

Desiree Requena-Lancharro (D)

Department of Applied Physics III, School of Engineering, Universidad de Sevilla, Camino de los Descubrimientos s/n, 41092, Sevilla, Spain.

Manuel Guerrero-Claro (M)

Department of Applied Physics III, School of Engineering, Universidad de Sevilla, Camino de los Descubrimientos s/n, 41092, Sevilla, Spain.

Pedro Gil-Gamboa (P)

Department of Applied Physics III, School of Engineering, Universidad de Sevilla, Camino de los Descubrimientos s/n, 41092, Sevilla, Spain.

Cristina Rosell-Valle (C)

Institute of Biomedicine of Seville, 41013, Sevilla, Spain.
Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza de Diseño y Traslación de Terapias Avanzadas, 41092, Sevilla, Spain.

Carmen Gomez-Gonzalez (C)

Service of Intensive Care, University Hospital 'Virgen del Rocio', 41013, Sevilla, Spain.

Maria Jose Mayorga-Buiza (MJ)

Institute of Biomedicine of Seville, 41013, Sevilla, Spain.
Service of Anaesthesiology, University Hospital 'Virgen del Rocio', 41013, Sevilla, Spain.

Maria Martin-Lopez (M)

Institute of Biomedicine of Seville, 41013, Sevilla, Spain.
Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza de Diseño y Traslación de Terapias Avanzadas, 41092, Sevilla, Spain.

Olga Muñoz (O)

Instituto de Astrofísica de Andalucía, CSIC, 18008, Granada, Spain.

Juan Carlos Gomez Martin (JCG)

Instituto de Astrofísica de Andalucía, CSIC, 18008, Granada, Spain.

Maria Isabel Relimpio Lopez (MIR)

Department of Ophthalmology, University Hospital 'Virgen Macarena', 41009, Sevilla, Spain.
OftaRed, Institute of Health 'Carlos III', 28029, Madrid, Spain.

Jesus Aceituno-Castro (J)

Instituto de Astrofísica de Andalucía, CSIC, 18008, Granada, Spain.
Centro Astronomico Hispano Alemán, 04550, Almeria, Spain.

Manuel A Perales-Esteve (MA)

Department of Electronic Engineering, School of Engineering, Universidad de Sevilla, 41092, Sevilla, Spain.

Antonio Puppo-Moreno (A)

Service of Intensive Care, University Hospital 'Virgen del Rocio', 41013, Sevilla, Spain.

Francisco Jose Garcia Cozar (FJG)

Department of Biomedicine, Biotechnology and Public Health, University of Cadiz, 11003, Cadiz, Spain.

Lucia Olvera-Collantes (L)

Instituto de Investigación E Innovación Biomedica de Cádiz (INIBICA), 11009, Cadiz, Spain.

Silvia de Los Santos-Trigo (S)

Corporación Tecnológica de Andalucía, 41092, Sevilla, Spain.

Emilia Gomez (E)

Joint Research Centre, European Commission, 41092, Sevilla, Spain.

Rosario Sanchez Pernaute (RS)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza de Diseño y Traslación de Terapias Avanzadas, 41092, Sevilla, Spain.

Javier Padillo-Ruiz (J)

Institute of Biomedicine of Seville, 41013, Sevilla, Spain.
Department of General Surgery, University Hospital 'Virgen del Rocío', 41013, Sevilla, Spain.

Javier Marquez-Rivas (J)

Institute of Biomedicine of Seville, 41013, Sevilla, Spain.
Service of Neurosurgery, University Hospital 'Virgen del Rocío', 41013, Sevilla, Spain.
Centre for Advanced Neurology, 41013, Sevilla, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH